Akamai has agreed a deal of undisclosed size to acquire the identity authentication software provider, which had raised almost $79m from investors including Salesforce.
Author: Jack Hammond
GreenLight cultivates $50m in new funding
Alexandria Real Estate Equities and Continental Grain Company have backed the first close of the Syngenta-backed agricultural bioprocessing platform’s latest round.
Goldman Sachs spends $30m on InnoVid investment
The Cisco and Deutsche Telekom-backed video advertising software provider has received capital from Goldman Sachs that it described as pre-IPO funding.
Bowery Valuation builds $12m series A round
Existing investor Camber Creek returned for a round that increased the total raised by the property appraisal software provider to $19m.
Horizn Studios carries away series B funding
Vorwerk Ventures returned to reinvest in the smart luggage developer as part of an $11.4m round that also featured Project A and Milano Investment Partners.
Frequency tunes into $42m
Proceeds from the Alexandria Real Estate Equities-backed series B round will advance the company’s development of progenitor cell-related medicines for hearing loss.
Celgene injects $30m into NantCell
NantCell received the funding at a $4bn valuation, giving existing investor Celgene a 2.8% stake in the cancer immunotherapy developer.
Pear prevails in $64m series C
Novartis returned to reinvest in digital medicine developer Pear Therapeutics as part of a Temasek-led round that took its overall funding to more than $134m.
Haoqipei hops to $60m series C
Access Industries and SIG participated in a series C round that came three months after the auto parts marketplace raised $20m in series B funding.
Super League seeks $25m in IPO
Cali Group owns a 17.6% in the online gaming platform and eSports tournament operator, whose other investors include Viacom, Axiomatic, DMG and Cinemark.
WeRide drives away with series A extension
SenseTime has helped the autonomous driving software developer expand a series A round already featuring Alliance Ventures and Johnson Electric.
Kang Sheng completes $100m series C round
Ping An, Samsung, CLP, Tasly and Health 100 have all taken part in a series C round for the diabetes management technology provider.
Sanofi hands $91m to Biontech
Biontech has received $91.5m in equity funding as part of the extension of a deal to develop a cancer immunotherapy candidate with Sanofi.
Miaoshou Doctor fulfils $73m funding prescription
The online pharmaceutical distributor has secured $73m in a series C-plus round that follows a Tencent-led round last April.